Skip to main content

Newsroom

Press Releases

November 14, 2017
GAITHERSBURG, Md., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has issued a Notice of Termination of Conversion Rights for all of its outstanding 2.875% Convertible Senior Notes due 2021 (“Notes”) and has elected to exercise its right to terminat...

 


Corporate Headquarters Ribbon Cutting

Media
Lynn R. Kieffer
kiefferl@ebsi.com 
TEL 240-631-3391 

Investors
Robert Burrows 
burrowsr@ebsi.com 
TEL 240-631-3280